Pharmidex attending FENS Neuroscience conference
Jun 23, 2018

Pharmidex will be attending this years FENS neuroscience conference, where the CNS team will be presenting a poster.

Pharmidex will presenting "Dopamine metabolism in striatum, and rearing behaviour, suggest different significance on the attenuation of nicotine-induced changes on total locomotor activity for Varenicline and Baclofen." 


The Abstract number for our presentation is F18-2414ABSTRACT. For more information please come and find our presentation as stated below!


Session Name: C. DISORDERS OF THE NERVOUS SYSTEM - C.15.l Psychiatric disorders: Addiction and drugs of abuse - part II


Date: 8 July 2018


Session Time: 14:00 - 17:30


Poster Board Number: C169

Combinatorial Therapy: Targeting CD133+ Glioma Stem-like Cells with a Polysaccharide-Prodrug Complex Functionalised Gold Nanocages

24 Apr, 2024
Pharmidex , in collaboration with colleagues at the University of Brighton, is pleased to announce publication of our latest article

Luminex cytokines Analysis

13 Mar, 2024
Uncover valuable insights from a range of sources including plasma, bronchoalveolar lavage fluid, urine, and tissue supernatant with our comprehensive matrix evaluation services.

Pharmidex GLP/GCP Bioanalysis Offer

By Ash Alavijeh • 26 Feb, 2024
As an accredited GLP/GCP laboratory, Pharmidex provides comprehensive bioanalytical solutions tailored to meet your specific drug development needs.
More Posts
Share by: